Kadmon D, Thompson T C, Lynch G R, Scardino P T
Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030.
J Urol. 1991 Aug;146(2):358-61. doi: 10.1016/s0022-5347(17)37793-5.
Chromogranin-A is considered a sensitive immunohistochemical tissue marker in neuroendocrine prostatic carcinoma. We report that the plasma chromogranin-A level was elevated in 48% of 25 patients with stage D2 prostate cancer, and suggest that this marker can be used to monitor the clinical course of these patients.
嗜铬粒蛋白A被认为是神经内分泌前列腺癌中一种敏感的免疫组化组织标志物。我们报告，在25例D2期前列腺癌患者中，48%的患者血浆嗜铬粒蛋白A水平升高，并提示该标志物可用于监测这些患者的临床病程。
